Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soon Jun Hong

Showing results (161-170 of 214) with videos related to

Pageof 22
Sort By:
JACC. Cardiovascular Interventions|June 18, 2022
Physiological Approach for Coronary Artery Bifurcation Disease: Position Statement by Korean, Japanese, and European Bifurcation ClubsHak Seung Lee, Ung Kim, Seokhun Yang, et al.
Journal of Hypertension|August 3, 2019
The association of smoothness index of central blood pressure with ambulatory carotid femoral pulse wave velocity after 20-week treatment with losartan in combination with amlodipine versus hydrochlorothiazideJinho Shin, Hae Young Lee, Wook Jin Chung, et al.
JAMA Cardiology|March 9, 2022
Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the HOST-REDUCE-POLYTECH-ACS TrialDoyeon Hwang, Young-Hyo Lim, Kyung Woo Park, et al.
Journal of the American Heart Association|May 18, 2024
Prognostic Impact of <i>CYP2C19</i> Genotypes on Long-Term Clinical Outcomes in Older Patients After Percutaneous Coronary InterventionJu Hyeon Kim, Seung-Jun Lee, Jung-Joon Cha, et al.
Scientific Reports|January 4, 2024
High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantationSubin Lim, Soon Jun Hong, Ju Hyeon Kim, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 25, 2023
Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertensionKi-Chul Sung, Soon Jun Hong, Moo-Yong Rhee, et al.
Circulation|August 27, 2023
Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided Percutaneous Coronary Intervention: The OCTIVUS Randomized Clinical TrialDo-Yoon Kang, Jung-Min Ahn, Sung-Cheol Yun, et al.
Medicine|November 28, 2023
Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III studySeung-Ah Lee, Soon Jun Hong, Jung-Hoon Sung, et al.
Journal of the American College of Cardiology|October 25, 2023
Guiding Intervention for Complex Coronary Lesions by Optical Coherence Tomography or Intravascular UltrasoundDo-Yoon Kang, Jung-Min Ahn, Sung-Cheol Yun, et al.
Cardiovascular Drugs and Therapy|April 13, 2010
A multicenter, eight-week treatment, single-step titration, open-label study assessing the percentage of Korean dyslipidemic patients achieving LDL cholesterol target with atorvastatin starting doses of 10 mg, 20 mg and 40 mgCheol Whan Lee, Sang-Hong Baek, Taek-Jong Hong, et al.
Pageof 22

Showing results (161-170 of 214) with videos related to

Sort By:
Pageof 22
JACC. Cardiovascular Interventions|June 18, 2022
Physiological Approach for Coronary Artery Bifurcation Disease: Position Statement by Korean, Japanese, and European Bifurcation ClubsHak Seung Lee, Ung Kim, Seokhun Yang, et al.
Journal of Hypertension|August 3, 2019
The association of smoothness index of central blood pressure with ambulatory carotid femoral pulse wave velocity after 20-week treatment with losartan in combination with amlodipine versus hydrochlorothiazideJinho Shin, Hae Young Lee, Wook Jin Chung, et al.
JAMA Cardiology|March 9, 2022
Prasugrel Dose De-escalation Therapy After Complex Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome: A Post Hoc Analysis From the HOST-REDUCE-POLYTECH-ACS TrialDoyeon Hwang, Young-Hyo Lim, Kyung Woo Park, et al.
Journal of the American Heart Association|May 18, 2024
Prognostic Impact of <i>CYP2C19</i> Genotypes on Long-Term Clinical Outcomes in Older Patients After Percutaneous Coronary InterventionJu Hyeon Kim, Seung-Jun Lee, Jung-Joon Cha, et al.
Scientific Reports|January 4, 2024
High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantationSubin Lim, Soon Jun Hong, Ju Hyeon Kim, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|April 25, 2023
Comparison of efficacy and safety between third-dose triple and third-dose dual antihypertensive combination therapies in patients with hypertensionKi-Chul Sung, Soon Jun Hong, Moo-Yong Rhee, et al.
Circulation|August 27, 2023
Optical Coherence Tomography-Guided or Intravascular Ultrasound-Guided Percutaneous Coronary Intervention: The OCTIVUS Randomized Clinical TrialDo-Yoon Kang, Jung-Min Ahn, Sung-Cheol Yun, et al.
Medicine|November 28, 2023
Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III studySeung-Ah Lee, Soon Jun Hong, Jung-Hoon Sung, et al.
Journal of the American College of Cardiology|October 25, 2023
Guiding Intervention for Complex Coronary Lesions by Optical Coherence Tomography or Intravascular UltrasoundDo-Yoon Kang, Jung-Min Ahn, Sung-Cheol Yun, et al.
Cardiovascular Drugs and Therapy|April 13, 2010
A multicenter, eight-week treatment, single-step titration, open-label study assessing the percentage of Korean dyslipidemic patients achieving LDL cholesterol target with atorvastatin starting doses of 10 mg, 20 mg and 40 mgCheol Whan Lee, Sang-Hong Baek, Taek-Jong Hong, et al.
Pageof 22